Head and Neck Cancer Trial, Recruiting NCT05030597 Sponsor: Zhongnan Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05030597
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to take part and have signed a consent form agreeing to participate
  • People aged between 18 and 70 years old
  • People who have a strong clinical suspicion of oral cancer, or whose oral cancer has come back after previous treatment (newly diagnosed patients must be scheduled for surgery, or for pre-surgery treatment followed by surgery)
  • People who are able to complete the required PET/CT scans at the start of the study and at follow-up appointments (follow-up scans using FAPI apply only to patients with more advanced cancer who are receiving pre-surgery treatment)

Who may not be able to join:

  • Women who are pregnant, breastfeeding, or planning to become pregnant during the trial period
  • People who have a known allergy to the imaging substances FAPI or FDG, or who have had a serious allergic reaction in the past
  • People whose overall health is too poor, or whose heart, lungs, liver, kidneys, or other major organs are not strong enough to withstand surgery
  • People whose blood sugar level was above 11.0 mmol/L after fasting, measured before the FDG injection
  • People who experience severe anxiety in enclosed spaces (claustrophobia), or who are unable to lie still on their back for 15 to 30 minutes during the scan
  • People who have taken part in another interventional clinical trial within the 30 days before enrolling, or who plan to join another such trial during this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: He Yong, PhD, Zhongnan Hospital

Phone: 0086-027-67812698

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongnan Hospital
Registry
ClinicalTrials.gov
Start date
15 September 2021
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic performance (sensitivity, specificity, accuracy) and staging of FAPI PET in oral cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov